Loading…
Evolus, Inc. is projected to rise to $7.55 by 2027, a +29% move from its current price of $5.84. EOLS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $5.71 | $5.84 | $5.98 | 0.00% |
| Aug 4 | $5.65 | $5.84 | $6.04 | 0.00% |
| Aug 5 | $5.61 | $5.84 | $6.08 | -0.01% |
| Aug 6 | $5.57 | $5.84 | $6.12 | -0.01% |
| Aug 7 | $5.54 | $5.84 | $6.15 | -0.01% |
| Aug 8 | $5.51 | $5.84 | $6.18 | -0.01% |
| Aug 9 | $5.49 | $5.84 | $6.21 | -0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.49 | $5.84 | $6.21 | -0.02% |
| Week 2 | $5.35 | $5.84 | $6.37 | -0.03% |
| Week 3 | $5.25 | $5.84 | $6.50 | -0.05% |
| Week 4 | $5.16 | $5.84 | $6.60 | -0.06% |
| Week 5 | $5.08 | $5.84 | $6.70 | -0.08% |
| Week 6 | $5.02 | $5.83 | $6.79 | -0.09% |
| Week 7 | $4.95 | $5.83 | $6.87 | -0.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Evolus, Inc. is a performance beauty company that delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.
Evolus also offers Evolysse, a collection of injectable hyaluronic acid gels, which includes products for mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Evolus is categorized within Healthcare.
Evolus, Inc. (EOLS) is the issuer of Jeuveau and Evolysse in the cash-pay aesthetic market. The current price is $5.96 per share. Its market capitalization is $392.49M and it is ranked 3256.
Forecasts indicate a near-flat average for 2026 at $5.96 with a NEUTRAL sentiment, suggesting little change on average this year. From 2027 onward, the outlook turns bullish with rising averages and higher potential.
By 2030 the forecast average is $10.18, and by 2040 it is $21.63, with a further rise to $39.41 by 2050. The associated ROI figures rise from 70.8% in 2030 to 262.9% in 2040 and 561.3% in 2050, all with bullish sentiment.
A major floor 32.5% below — a decisive break under it would weaken the trend.
The nearest floor, 5.1% below — buyers have tended to step in here.
The nearest ceiling, 22.4% above — a clean break opens room to run.
A major ceiling 33.3% above — clearing it would confirm fresh momentum.
Key EOLS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EOLS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.06 | Sell | $5.98 | Sell |
| MA 10 | $5.95 | Sell | $6.02 | Sell |
| MA 20 | $6.19 | Sell | $6.15 | Sell |
| MA 50 | $6.46 | Sell | $6.22 | Sell |
| MA 100 | $5.78 | Buy | $6.07 | Sell |
| MA 200 | $5.88 | Sell | $6.39 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.67 | Neutral |
| Stoch RSI (14) | 56.19 | Neutral |
| CCI (20) | -63.26 | Neutral |
| Williams %R (14) | -59.31 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -2.01 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 40.69 | Neutral |
| TRIX (15) | -0.39 | Sell |
| Awesome (5,34) | -0.40 | Sell |
| Ultimate (7,14,28) | 42.41 | Neutral |
| Momentum (10) | 0.11 | Buy |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 6.03 | Sell |
| ADX (14) | 18.80 | Neutral |
| ATR (14) | 0.14 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 30. The 50-day simple moving average sits at $6.57 and the 200-day simple moving average sits at $5.90, placing the price near these moving averages.
Support and resistance levels are $5.96 and $7.15 respectively, with a 30-day price range of $5.09 to $6.98. Annualized volatility is 50%.
These metrics frame a market where near-term upside is possible but not yet implied, given the current price relative to key levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.94 | $5.84 | $7.50 | 0% | Neutral | |
| $6.10 | $7.55 | $9.83 | +29% | Bullish | |
| $7.15 | $9.06 | $12.19 | +55% | Bullish | |
| $7.66 | $9.89 | $13.65 | +69% | Bullish | |
| $8.28 | $10.88 | $15.34 | +86% | Bullish | |
| $8.37 | $11.18 | $16.06 | +91% | Bullish | |
| $8.99 | $12.18 | $17.79 | +108% | Bullish | |
| $9.95 | $13.67 | $20.28 | +134% | Bullish | |
| $11.11 | $15.45 | $23.26 | +165% | Bullish | |
| $13.11 | $18.45 | $28.14 | +216% | Bullish | |
| $16.87 | $25.08 | $40.42 | +329% | Bullish | |
| $28.60 | $46.66 | $81.54 | +699% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.94 | $5.84 | $7.05 | +0.00% |
| September 2026 | $5.07 | $5.97 | $7.22 | +2.27% |
| October 2026 | $4.92 | $5.83 | $7.11 | -2.42% |
| November 2026 | $4.88 | $5.81 | $7.14 | -0.27% |
| December 2026 | $5.07 | $6.07 | $7.50 | +4.36% |
Click any year to see its month-by-month EOLS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Evolus, Inc.'s 2026 outlook centres on $5.84, within a $3.94 to $7.50 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, EOLS could reach as high as $9.83, with a base case around $7.55 and support toward $6.10 — roughly +29% from $5.84. Buyers look set to stay in control over this stretch.
Expect EOLS to range from $7.15 to $12.19 through 2028. The $9.06 average target implies a +55% move from current prices. That is up +20% on the projected 2027 average. Momentum favours further upside here.
The EOLS price prediction for 2029 points to an average of $9.89 (low $7.66, high $13.65) — a potential gain of +69% on today's $5.84. Buyers look set to stay in control over this stretch.
In 2030, EOLS is projected to trade between $8.28 and $15.34, averaging $10.88 — a potential gain of +86% from today's $5.84. That is up +10% on the projected 2029 average. Momentum favours further upside here.
Evolus, Inc.'s 2031 outlook centres on $11.18, within a $8.37 to $16.06 range. That is up +3% on the projected 2030 average. That marks a +91% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, EOLS could reach as high as $17.79, with a base case around $12.18 and support toward $8.99 — roughly +108% from $5.84. Momentum favours further upside here.
Expect EOLS to range from $9.95 to $20.28 through 2033. The $13.67 average target implies a +134% move from current prices. That is up +12% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The EOLS price prediction for 2034 points to an average of $15.45 (low $11.11, high $23.26) — a potential gain of +165% on today's $5.84. Momentum favours further upside here.
In 2035, EOLS is projected to trade between $13.11 and $28.14, averaging $18.45 — a potential gain of +216% from today's $5.84. That is up +19% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Evolus, Inc.'s 2040 outlook centres on $25.08, within a $16.87 to $40.42 range. That is up +36% on the projected 2035 average. That marks a +329% change versus current levels. Momentum favours further upside here.
By 2050, EOLS could reach as high as $81.54, with a base case around $46.66 and support toward $28.60 — roughly +699% from $5.84. Buyers look set to stay in control over this stretch.
Investing $1,000 in EOLS today (≈ 171.232877 EOLS) could be worth
$7,989.36
+$6,989.36 (+699%) by 2050 · US Dollar
Based on the average projected EOLS price of $46.66 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EOLSwould be worth at today's price.
$1,000 invested in EOLS on Jul 31, 2025 (≈ 112.107622 EOLS) would be worth
$654.71
-$345.29 (-34.5%) today · 0.65× · US Dollar
Based on a EOLS entry price of $8.92 vs. today's $5.84.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.98 | $976.59 | -2.3% |
| 1 month ago | $6.74 | $866.47 | -13.4% |
| 3 months ago | $5.33 | $1,095.68 | +9.6% |
| 6 months ago | $4.91 | $1,189.41 | +18.9% |
| 1 year ago | $8.92 | $654.71 | -34.5% |
| All time (5.0y) ago | $11.33 | $515.45 | -48.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EOLS forecast.
Our base-case forecast reaches $12.00 around 2032.
Implied market cap at $12.00: $790.26M
Looking across the multi-year forecast, sentiment shifts from NEUTRAL in 2026 to BULLISH from 2027 onward, with rising averages and meaningful upside potential. The 2027 average is $7.35 and 2028 is $8.91, with steadily improving momentum.
In 2030, the average forecast reaches $10.18, with a ROI of 70.8% and a BULLISH sentiment. The trajectory continues toward 2040, where the average is $21.63 and ROI is 262.9%, followed by 2050 with an average of $39.41 and ROI of 561.3%.
These are estimates, not guarantees, and reflect sources’ projected paths under the provided assumptions. They illustrate a rising long-term value trend if the forecast materializes, but actual results can differ due to market and company factors.
Tap a question to reveal the answer.
2030 avg is $10.18, with min $7.71 and max $14.44, ROI 70.8%, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages and positive ROI (23.4% in 2027 to 561.3% in 2050). 2026 is NEUTRAL.
Yes. The 2040 forecast average is $21.63, with ROI 262.9% and sentiment BULLISH.
Current price is $5.96 and market cap is $392.49M.
RSI14 is 30. SMA(50) is $6.57 and SMA(200) is $5.90. Support is $5.96 and resistance is $7.15. The 30-day range is $5.09-$6.98 with annualized volatility of 50%.
Evolus, Inc. Community Discussion
0Share your Evolus, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.